Nabsys

Founded in 2005, Nabsys emerged as the very first life science company to call Rhode Island its home. The story of Nabsys began with a merger of two small startups rooted within the Brown University ecosystem. At its core, Nabsys is the torchbearer of electronic genome mapping using solid-state nanodetection, a groundbreaking technology with applications in DNA analysis. Nabsys harnessed the potential of solid-state nanodetectors, ushering in an era where single DNA molecules are meticulously analyzed to reveal both their location and identity over vast stretches, introducing a new technology to view genomes as whole using long-range genomic data. Nabsys was honored to be the recipient of the prestigious “$1,000 Genome” award from the National Human Genome Research Institute, a testament to our electronic approach to DNA sequencing. Today, Nabsys stands at the threshold of a new era in genomics with the introduction of the OhmX platform. Nabsys’s technology can detect structural variants ranging from approximately 300bp in size to large chromosomal rearrangements with read lengths over 100kb. Nabsys currently boasts 17 patent families, a testament to our pioneering spirit and dedication to advancing genomics.